Trademark: 97401659
Status Date
Friday, April 12, 2024
Filing Date
Monday, May 9, 2022
5 Pharmaceuticals for treatment of ophthalmic diseases and conditions; Ophthalmic preparations; Pharmaceutical preparations for the treatment of eye diseases and conditions; Medical inserts namely, implantable intravitreal drug delivery devices sold filled with ophthalmic pharmaceutical preparations for treating glaucoma, dry eye disease, macular degeneration, and lowering intraocular pressure; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, and macular degeneration; Pharmaceutical preparations for the treatment of lowering intraocular pressure; Medical insert, namely, implantable intravitreal drug delivery devices sold filled with pharmaceutical preparations in the nature of dexamethasone for the treatment of eye diseases and conditions; Medical insert, namely, implantable intravitreal drug delivery devices sold filled with pharmaceutical preparations in the nature of dexamethasone for post-op pain and inflammation of the eye, and itching associated with allergic conjunctivitis
42 Research and development in the pharmaceutical and biopharmaceutical fields; Development of pharmaceutical and biopharmaceutical preparations, inserts, implants, and medicines; Pharmaceutical and biopharmaceutical products development
The mark consists of the word "OCULAR" in a stylized font with a larger, stylized letter "O", which is positioned above a horizontal line, and the stylized word "THERAPEUTIX" in a stylized font, which is positioned below the horizontal line. A shaded diamond forms the dot above the lower case letter "I" in the word "THERAPEUTIX".
OCULAR THERAPEUTIC
Color is not claimed as a feature of the mark.
OCULAR
May 17, 2022
Notice Of Design Search Code E-Mailed
May 12, 2022
New Application Entered
May 16, 2022
New Application Office Supplied Data Entered
Oct 10, 2022
Teas Change Of Owner Address Received
Oct 10, 2022
Teas Change Of Correspondence Received
Oct 10, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 30, 2022
Assigned To Examiner
Dec 2, 2022
Non-Final Action Written
Dec 2, 2022
Non-Final Action E-Mailed
Dec 2, 2022
Notification Of Non-Final Action E-Mailed
Jun 2, 2023
Teas Response To Office Action Received
Nov 5, 2023
Assigned To Lie
Nov 5, 2023
Correspondence Received In Law Office
Nov 5, 2023
Teas/Email Correspondence Entered
Dec 6, 2023
Non-Final Action Written
Dec 6, 2023
Non-Final Action E-Mailed
Dec 6, 2023
Notification Of Non-Final Action E-Mailed
Mar 4, 2024
Teas Response To Office Action Received
Mar 6, 2024
Correspondence Received In Law Office
Mar 6, 2024
Teas/Email Correspondence Entered
Apr 12, 2024
Teas/Email Correspondence Entered
Apr 12, 2024
Correspondence Received In Law Office
Apr 12, 2024
Teas Response To Office Action Received
Apr 3, 2024
Notification Of Non-Final Action E-Mailed
Apr 3, 2024
Non-Final Action Written
Apr 3, 2024
Non-Final Action E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
